
DuoResp Spiromax - European Medicines Agency (EMA)
DuoResp Spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with COPD with forced expiratory volume in 1 second (FEV?) <70% predicted normal (post bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.
DuoResp Spiromax 160 micrograms / 4.5 micrograms inhalation …
2024年4月5日 · DuoResp Spiromax should be used correctly in order to achieve effective treatment. As such, the patients should be advised to read the patient information leaflet carefully and follow the instructions for use as detailed in the leaflet. The use of DuoResp Spiromax follows three steps: open, breathe and close which are outlined below.
DuoResp Spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with COPD with forced expiratory volume in 1 second (FEV1) < 70% predicted normal (post bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.
梯瓦 DuoResp Spiromax 获欧盟上市许可 - PhIRDA
DuoResp Spiromax 是一种新型含 布地奈德 和福莫特罗富马酸盐二水合物的多剂量 干粉 吸入器,布地奈德为皮质类固醇类,吸入后可治疗哮喘和慢性阻塞性肺病的潜在炎症, 福莫特罗其中有 速效和长效剂型,它是 选择性 β2 -肾上腺素受体激动剂,用以缓解 哮喘和 ...
- [PDF]
Spiromax 使用说明
如何使用Spiromax®吸入器? 请您保持站立或坐下,以最放松的方式完成 下列操作: 1. 保持吸入器直立,向下打开 盖子直至听到“咔哒”声。 每打开一次盖子,则吸入器 上药一次。初始剂量为60剂。 2. 将肺部空气全部排出(请勿吹喷嘴)。 3. 将喷嘴在嘴中放好,
Spiromax, a New Dry Powder Inhaler: Dose Consistency under
Background: Spiromax(®) is a novel dry powder inhaler for patients with asthma or chronic obstructive pulmonary disease (COPD). The studies presented here provide further data on attributes (in vitro dosing consistency with budesonide-formoterol (DuoResp) Spiromax; flow rates through empty versions of the Spiromax and Turbuhaler inhaler) of ...
梯瓦用于哮喘及COPD的吸入器DuoResp Spiromax获欧盟批准 - 丁 …
DuoResp Spiromax是一种含有布地奈德与富马酸福莫特罗固定剂量组合(FDC)的新型、多剂量干粉吸入器,其中布地奈德是一种吸入性糖皮质激素,用于治疗哮喘及COPD潜在的炎症,富马酸福莫特罗是速效及长效的β2肾上腺素受体激动剂,用来缓解哮喘及COPD的支气管缩小。
Spiromax, a New Dry Powder Inhaler: Dose Consistency under …
Background: Spiromax® is a novel dry powder inhaler for patients with asthma or chronic obstructive pulmonary disease (COPD). The studies presented here provide further data on attributes (in vitro dosing consistency with budesonide–formoterol ...
DuoResp Spiromax - NPS MedicineWise
2021年6月1日 · DUORESP SPIROMAX is inhaled into the lungs for the treatment of asthma or Chronic Obstructive Pulmonary Disease (COPD). ASTHMA. Asthma is a disease where the airways of the lungs become narrow and inflamed (swollen), making it difficult to breathe.
DuoResp Spiromax - Healthify
2024年12月16日 · DuoResp Spiromax® is a combination of 2 medicines, budesonide and formoterol, in a single inhaler. DuoResp Spiromax is used to treat the symptoms of asthma and COPD and to prevent them from recurring. Budesonide is a corticosteroid. When inhaled it prevents swelling and irritation in the walls of the small air passages in your lungs.